3-8629684-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001256748.3(SSUH2):c.568G>A(p.Gly190Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000951 in 1,230,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001256748.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSUH2 | NM_001256748.3 | c.568G>A | p.Gly190Ser | missense_variant | 7/12 | ENST00000544814.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSUH2 | ENST00000544814.7 | c.568G>A | p.Gly190Ser | missense_variant | 7/12 | 2 | NM_001256748.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000122 AC: 13AN: 106786Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000756 AC: 18AN: 238250Hom.: 0 AF XY: 0.0000774 AC XY: 10AN XY: 129132
GnomAD4 exome AF: 0.0000925 AC: 104AN: 1123778Hom.: 0 Cov.: 32 AF XY: 0.0000906 AC XY: 51AN XY: 562990
GnomAD4 genome AF: 0.000122 AC: 13AN: 106928Hom.: 0 Cov.: 30 AF XY: 0.0000958 AC XY: 5AN XY: 52184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2024 | The c.502G>A (p.G168S) alteration is located in exon 7 (coding exon 4) of the SSUH2 gene. This alteration results from a G to A substitution at nucleotide position 502, causing the glycine (G) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at